Equities

Panacea Life Sciences Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
PLSH:PKC

Panacea Life Sciences Holdings Inc

Actions
  • Price (USD)0.04
  • Today's Change0.00 / 0.00%
  • Shares traded56.88k
  • 1 Year change-25.79%
  • Beta2.9908
Data delayed at least 15 minutes, as of Feb 03 2026 20:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Panacea Life Sciences Holdings, Inc. is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, research, and distribution of products within natural health and wellness market segment for both humans and animals. The Company's subsidiary, Panacea Life Sciences, Inc., is dedicated to the distribution of nutraceuticals, cannabinoids and other natural, plant-based ingredients and products. The Company offers pure natural remedies within various product lines: PANA Life, PANA Beauty, PANA Sport, PANA Pet and PANA Health. It sells over 40 different product SKUs of CBD and CBG products. Its products are formulated with delivery methods for health benefits including an intellectual property portfolio enabling development of topical creams, sublinguals, oral soft gel capsules, patches, and sprays. Its Benivita PLSH provides access to non-insurance benefits, virtual telemedicine services, and lifestyle wellness programs.

  • Revenue in USD (TTM)2.76m
  • Net income in USD-7.67m
  • Incorporated2008
  • Employees40.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pure Harvest Corporate Group Inc2.48m-6.67m861.66k25.00--0.3823--0.3479-0.0901-0.09010.03830.02010.26441.4640.6499,070.40-70.96---136.76--33.83---268.37--0.5886-0.8660.7639--1,808.41---459.26------
American Green Inc-100.00bn-100.00bn868.45k6.00------------------------------------------------------------
ITonis Inc0.00-1.17m914.05k-----------0.0012-0.00120.00-0.00040.00-------187.63---1,169.36-------------0.8999---------506.86------
Vitalibis Inc243.57k-3.96m1.03m0.00------4.21-0.1103-0.11030.0034-0.00690.52010.352-----844.71-1,100.84----51.56---1,624.14-2,623.600.5512-2.33----490.69---207.18------
Evofem Biosciences Inc17.73m-5.56m1.18m32.00------0.0665-0.058-0.0580.0111-0.56610.93922.253.61553,937.50-28.79-177.41----80.0569.60-30.66-602.270.0797-0.2439----6.28---117.93---38.87--
Procyon Corp4.98m-312.97k1.53m19.00--0.7027--0.307-0.0387-0.03870.61380.28171.472.329.90262,338.40-10.081.19-12.701.4478.0774.40-6.840.86912.41--0.00--6.353.53-367.38--17.32--
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
Panacea Life Sciences Holdings Inc2.76m-7.67m1.69m40.00------0.6102-0.4554-0.45540.164-0.52550.15371.6210.1369,098.25-42.65-69.04---225.03-139.49-181.62-277.51-505.410.0285-2.122.58--46.59--12.33------
Onconetix Inc1.22m-50.85m1.82m5.00--0.5412--1.49-350.74-350.742.142.160.031.3124.33244,750.00-120.44-82.49-240.72-114.7185.41---4,015.56-4,434.980.0706-17.940.0453--4,216.95---57.44--44.62--
Bio Essence Corp565.67k-160.45k2.08m2.00------3.67-0.0042-0.00420.0149-0.08161.26--16.06282,835.00-35.64-40.94----69.2838.36-28.36-134.00---57.42-------17.08-286.98------
Universe Pharmaceuticals Inc17.86m-3.67m2.24m216.00--0.0399--0.1256-10.13-10.1339.1899.640.26025.881.3882,679.35-5.35-5.40-7.08-7.0935.2843.33-20.56-9.653.90-17.460.1416---22.44-10.2757.92--46.30--
PRF Technologies Ltd0.00-4.09m2.32m2.000.00980.1412----301.27301.270.0020.970.00----0.00-57.27-71.03-118.06-84.02------------0.00-------56.12------
Data as of Feb 03 2026. Currency figures normalised to Panacea Life Sciences Holdings Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.